Generic name: MELOXICAM 7.5mg in 5mL
Dosage form: tablets and oral suspension
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
General Dosing Instructions
Carefully consider the potential benefits and risks of MOBIC and other treatment options before deciding to use MOBIC. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions (5)].
In adults, the maximum recommended daily oral dose of MOBIC is 15 mg regardless of formulation. In patients with hemodialysis, a maximum daily dosage of 7.5 mg is recommended [see Use in Specific Populations (8.7) and Clinical Pharmacology (12.3)].
For the relief of the signs and symptoms of osteoarthritis the recommended starting and maintenance oral dose of MOBIC is 7.5 mg once daily. Some patients may receive additional benefit by increasing the dose to 15 mg once daily.
For the relief of the signs and symptoms of rheumatoid arthritis, the recommended starting and maintenance oral dose of MOBIC is 7.5 mg once daily. Some patients may receive additional benefit by increasing the dose to 15 mg once daily.
Juvenile Rheumatoid Arthritis (JRA) Pauciarticular and Polyarticular Course
To improve dosing accuracy in smaller weight children, the use of the MOBIC oral suspension is recommended. MOBIC oral suspension is available in the strength of 7.5 mg/5 mL. For the treatment of juvenile rheumatoid arthritis, the recommended oral dose of MOBIC is 0.125 mg/kg once daily up to a maximum of 7.5 mg. There was no additional benefit demonstrated by increasing the dose above 0.125 mg/kg once daily in these clinical trials.
|12 kg (26 lb)||1.0 mL||1.5 mg|
|24 kg (54 lb)||2.0 mL||3.0 mg|
|36 kg (80 lb)||3.0 mL||4.5 mg|
|48 kg (106 lb)||4.0 mL||6.0 mg|
|≥60 kg (132 lb)||5.0 mL||7.5 mg|
In patients on hemodialysis, the maximum dosage of MOBIC is 7.5 mg per day [see Clinical Pharmacology (12.3)].
Non-Interchangeability with Other Formulations of Meloxicam
MOBIC Tablets and MOBIC Suspension have not shown equivalent systemic exposure to other approved formulations of oral meloxicam. Therefore, MOBIC Tablets and MOBIC Suspension are not interchangeable with other formulations of oral meloxicam product even if the total milligram strength is the same. Do not substitute similar dose strengths of MOBIC Tablets or MOBIC Suspension with other formulations of oral meloxicam product.
More about Mobic (meloxicam)
- Other brands: Vivlodex